KODKodiak Sciences Inc.

KOD Stock Price, Valuation & Chart | Kodiak Sciences Inc.

Compare

$39.460+2.24 (+6.02%)

At close · 25 Aug 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology KOD intrinsic value Is KOD overvalued or undervalued

Overview Financials Dividends Ratios

KOD Historical price chart

KOD Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.47B

PE Ratio-9.46

EPS-4.17

Trading Volume498.84K

Today's High/Low39.68/37.71

Dividend Yield0.00

52 Week High/Low47.84/8.29

Shares Outstanding62.58M

KOD Financial Statement

KOD Analyst ratings

KOD Analysis & performance metrics

KOD Company profile

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate…

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic…

KOD Management team

Name

Position

Almas Qudrat M.Sc.

Chief Quality Officer

Dolly S. Chang M.D., M.P.H., Ph.D.

Chief Scientific Officer

Victor Perlroth M.D.CEO

Co-Founder, Chairman, Chief Executive Officer & President

Laurent Ducay Ph.D.

Senior Vice President of Biologics Development & Manufacturing

Hong Liang Ph.D.

Senior Vice President of Development

Stephen Raillard Ph.D.

Senior Vice President of Chemical Development & Manufacturing

John A. Borgeson CPA, M.B.A.CFO

Executive Vice President, Chief Financial Officer & Secretary

J. Pablo Velazquez-Martin M.D.

Chief Medical Officer

Name

Position

Almas Qudrat M.Sc.

Chief Quality Officer

Dolly S. Chang M.D., M.P.H., Ph.D.

Chief Scientific Officer

Victor Perlroth M.D.CEO

Co-Founder, Chairman, Chief Executive Officer & President

Laurent Ducay Ph.D.

Senior Vice President of Biologics Development & Manufacturing

Hong Liang Ph.D.

Senior Vice President of Development

Stephen Raillard Ph.D.

Senior Vice President of Chemical Development & Manufacturing

John A. Borgeson CPA, M.B.A.CFO

Executive Vice President, Chief Financial Officer & Secretary

J. Pablo Velazquez-Martin M.D.

Chief Medical Officer

Management Team

Almas Qudrat M.Sc.

Chief Quality Officer

Dolly S. Chang M.D., M.P.H., Ph.D.

Chief Scientific Officer

Victor Perlroth M.D.CEO

Co-Founder, Chairman, Chief Executive Officer & President

Laurent Ducay Ph.D.

Senior Vice President of Biologics Development & Manufacturing

Hong Liang Ph.D.

Senior Vice President of Development

Stephen Raillard Ph.D.

Senior Vice President of Chemical Development & Manufacturing

John A. Borgeson CPA, M.B.A.CFO

Executive Vice President, Chief Financial Officer & Secretary

J. Pablo Velazquez-Martin M.D.

Chief Medical Officer

Management

Almas Qudrat M.Sc.

Chief Quality Officer

Dolly S. Chang M.D., M.P.H., Ph.D.

Chief Scientific Officer

Victor Perlroth M.D.CEO

Co-Founder, Chairman, Chief Executive Officer & President

Laurent Ducay Ph.D.

Senior Vice President of Biologics Development & Manufacturing

Hong Liang Ph.D.

Senior Vice President of Development

Stephen Raillard Ph.D.

Senior Vice President of Chemical Development & Manufacturing

John A. Borgeson CPA, M.B.A.CFO

Executive Vice President, Chief Financial Officer & Secretary

J. Pablo Velazquez-Martin M.D.

Chief Medical Officer

Total 8 executives

KOD Frequently asked questions

What is Kodiak Sciences Inc. (KOD) Stock Price?

Current stock price of Kodiak Sciences Inc. (KOD) stock is $39.460. The stock price is +6.02% higher in the session. The intraday range can be seen from this page. Volume of Kodiak Sciences Inc. (KOD) stock is 498.84K.

Last updated at 25 Aug 2026, 08:00 pm.

Why is the Kodiak Sciences Inc. (KOD) stock price going up or down today?

The stock price of Kodiak Sciences Inc. (KOD) can change with earnings, company news, and overall market sentiment. Kodiak Sciences Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Kodiak Sciences Inc. stock expensive at its current price?

Whether Kodiak Sciences Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for KOD on this page is -9.46. EPS on this page is -4.17. Compare those figures with peers and growth expectations before deciding if the current Kodiak Sciences Inc. price is justified.

How has the stock price of Kodiak Sciences Inc. (KOD) performed historically?

Historical performance for Kodiak Sciences Inc. (KOD) is shown on the price chart on this page. Review multi-period moves alongside volume to see how KOD reacted to past earnings and market events.

Should I buy Kodiak Sciences Inc. (KOD) stock, at this price?

Buying Kodiak Sciences Inc. (KOD) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.